Genxone Spolka Akcyjna Logo

Genxone Spolka Akcyjna

A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.

GX1 | WAR

Overview

Corporate Details

ISIN(s):
PLGENXN00013
LEI:
25940043REFNZY18T558
Country:
Poland
Address:
SUCHY LAS ZŁOTNIKI, KOBALTOWA 6, 62-002 SUCHY LAS
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Genxone S.A. is a biotechnology company specializing in Next-Generation Sequencing (NGS) and medical diagnostics. The company provides nucleic acid (DNA and RNA) sequencing services based on innovative nanopore technology from Oxford Nanopore Technologies. As a pioneer in the field, it was the first laboratory in Poland and among the first globally to implement this technology for commercial use in science, business, and medicine. In addition to its sequencing services, Genxone develops and commercializes its own diagnostic products, including the NANOBIOME gut microbiome test.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-08 14:25
Regulatory News Service
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
Polish 1.2 KB
2024-03-06 16:41
Regulatory News Service
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
Polish 1.8 KB
2023-11-16 15:32
Related Party Transaction
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
Polish 1.1 KB
2023-11-14 14:32
Legal Proceedings Report
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
Polish 1.7 KB
2023-10-23 16:34
Regulatory News Service
Aktualizacja informacji na temat umowy warunkowej o istotnym znaczeniu - Conten…
Polish 948 bytes
2023-07-20 15:09
M&A Activity
Zawarcie istotnej umowy - Content (PL)
Polish 1.0 KB
2023-06-19 15:31
Declaration of Voting Results & Voting Rights Announcements
Lista akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 470 bytes
2023-05-22 15:37
Business and Financial Review
Sprawozdanie RN genXone za 2022 rok
Polish 991.6 KB
2023-05-22 15:37
Pre-Annual General Meeting Information
Projekty uchwał WZA genXone SA
Polish 284.6 KB
2023-05-22 15:37
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Spółki genXone SA
Polish 291.5 KB
2023-05-22 15:37
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Spółki genXone S.A. na d…
Polish 6.6 KB
2023-05-09 15:57
Related Party Transaction
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
Polish 857 bytes
2023-05-05 16:54
Related Party Transaction
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
Polish 1.5 KB
2023-04-26 17:03
Regulatory News Service
Aktualizacja informacji na temat prac badawczych w ramach projektu NANOBIOME - …
Polish 1.7 KB
2023-03-21 08:05
Director's Dealing
Zawiadomienia_o_transakcjach_osoby_zobowiazanej_Jakub_Swadzba_20230320.pdf
Polish 9.7 KB

Automate Your Workflow. Get a real-time feed of all Genxone Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Genxone Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom FUM
GENINCODE PLC Logo
AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.
United Kingdom GENI
Genomic Vision Logo
Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.
France GV
Hamlet BioPharma AB Logo
Developing selective therapies for cancer and infections like bladder cancer and UTIs.
Sweden HAMLET
Hipower Energy Spolka Akcyjna Logo
Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.
Poland HPE
Israel HRON

Talk to a Data Expert

Have a question? We'll get back to you promptly.